Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash Flows From Operating Activities:
Net loss	$ (6,356,053)	$ (2,790,505)	$ (11,033,580)	$ (7,314,519)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	233,821	(1,969,922)	183,164	(2,245,891)
Change in fair value of investment option liability	1,082,141		962,636
Change in fair value of derivative liability	(714,000)	53,000	(727,000)	53,000
Stock-based compensation			1,412,573	1,446,162
Amortization of right-of-use asset			54,703	68,910
Amortization of intangible assets	42,187	42,187	84,375	84,375
Depreciation expense	44,331	43,315	88,629	70,392
Gain on disposal of property and equipment			(4,212)
Change in operating assets and liabilities:
Prepaid expenses and other current assets			(1,111,913)	(1,031,979)
Accounts payable and accrued liabilities			542,397	(187,902)
Right-of-use operating lease liability			(54,702)	(76,686)
Net cash used in operating activities			(9,602,930)	(9,134,138)
Cash Flows From Investing Activities:
Purchases of property and equipment			(5,187)	(559,398)
Proceeds from disposal of property and equipment			16,872
Net cash used in investing activities			11,685	(559,398)
Cash Flows From Financing Activities:
Proceeds from sale of common stock, warrants, and investment options, net of offering costs				9,397,884
Redemption of Series A Preferred Stock (see Note 8)			(1,052,057)
Proceeds from the sale of redeemable non-controlling interest, net of offering				958,038
Net cash (used in) provided by financing activities			(1,052,057)	10,355,922
Effect of foreign exchange rate on cash			826	(9,434)
Net (decrease) increase in cash			(10,642,476)	652,952
Cash at beginning of period			17,723,884	17,355,999
Cash at end of period	7,081,408	18,008,951	7,081,408	18,008,951
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest			11	4,806
Income taxes paid
Warrants issued in conjunction with common stock issuance				3,595,420
Issuance of embedded derivative				402,000
Issuance of redeemable non-controlling Series C preferred stock				527
Preferred dividends attributable to redeemable non-controlling interest		7,808	19,041	7,808
Accretion of embedded derivative to redemption value	$ 36,997	$ 73,994	$ 147,988	$ 73,994